The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126044531 12604453 1 I 2015 20160718 20160728 20160728 EXP US-TEVA-678697USA TEVA 0.00 F Y 88.53000 KG 20160728 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126044531 12604453 1 PS AMPHETAMINE W/DEXTROAMPHETAMINE AMPHETAMINE SULFATEDEXTROAMPHETAMINE 1 60 MILLIGRAM DAILY; U 40422 30 MG BID
126044531 12604453 2 SS GRALISE GABAPENTIN 1 TITRATED UP TO 1800MG QD U MTFT7591 0
126044531 12604453 3 SS GRALISE GABAPENTIN 1 QD U MTFT7591 0 1200 MG
126044531 12604453 4 SS GRALISE GABAPENTIN 1 TITRATED GRADUALLY U MTFT7591 0
126044531 12604453 5 SS GRALISE GABAPENTIN 1 WITH EVENING MEAL U MTFT7591 0 1800 MG
126044531 12604453 6 SS PERCOCET ACETAMINOPHENOXYCODONE HYDROCHLORIDE 1 U 0
126044531 12604453 7 SS PERCOCET ACETAMINOPHENOXYCODONE HYDROCHLORIDE 1 TITRATED DOWN TO 5 MG U 0
126044531 12604453 8 C NICOTINE TRANSDERMAL SYSTEM NICOTINE 1 0
126044531 12604453 9 C PROPRANOLOL PROPRANOLOLPROPRANOLOL HYDROCHLORIDE 1 0
126044531 12604453 10 C CYCLOBENZAPRINE CYCLOBENZAPRINE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126044531 12604453 1 Attention deficit/hyperactivity disorder
126044531 12604453 2 Pain
126044531 12604453 6 Pain

Outcome of event

Event ID CASEID OUTC COD
126044531 12604453 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126044531 12604453 Abdominal distension
126044531 12604453 Amnesia
126044531 12604453 Blindness
126044531 12604453 Cough
126044531 12604453 Depressed mood
126044531 12604453 Drug dose omission
126044531 12604453 Drug ineffective for unapproved indication
126044531 12604453 Drug prescribing error
126044531 12604453 Dysuria
126044531 12604453 Euphoric mood
126044531 12604453 Fatigue
126044531 12604453 Feeling abnormal
126044531 12604453 Formication
126044531 12604453 Headache
126044531 12604453 Hypersomnia
126044531 12604453 Inappropriate schedule of drug administration
126044531 12604453 Incontinence
126044531 12604453 Incorrect dose administered
126044531 12604453 Malaise
126044531 12604453 Mental fatigue
126044531 12604453 Nausea
126044531 12604453 Off label use
126044531 12604453 Pain
126044531 12604453 Peripheral swelling
126044531 12604453 Sciatica
126044531 12604453 Somnolence
126044531 12604453 Urine odour abnormal
126044531 12604453 Weight increased
126044531 12604453 Withdrawal syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126044531 12604453 2 2015 2015 0
126044531 12604453 3 2015 2015 0
126044531 12604453 4 2015 20150325 0
126044531 12604453 5 20160330 0
126044531 12604453 6 2015 0
126044531 12604453 7 2015 201602 0
126044531 12604453 9 2015 0